Literature DB >> 9728001

Regulating the use of antibiotics in the community.

C Carbon1, R P Bax.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9728001      PMCID： PMC1113840          DOI： 10.1136/bmj.317.7159.663

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

1.  Trends in antimicrobial drug use in the community--France, 1981-1992.

Authors:  D Guillemot; P Maison; C Carbon; B Balkau; F Vauzelle-Kervroëdan; C Sermet; G Bouvenot; E Eschwège
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

2.  Antibiotic resistance: a view from the pharmaceutical industry.

Authors:  R P Bax
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

3.  Inappropriateness and variability of antibiotic prescription among French office-based physicians.

Authors:  D Guillemot; C Carbon; F Vauzelle-Kervroëdan; B Balkau; P Maison; G Bouvenot; E Eschwège
Journal:  J Clin Epidemiol       Date:  1998-01       Impact factor: 6.437

4.  Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child.

Authors:  E L Kaplan; F H Top; B A Dudding; L W Wannamaker
Journal:  J Infect Dis       Date:  1971-05       Impact factor: 5.226

5.  New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective.

Authors:  I Chopra; J Hodgson; B Metcalf; G Poste
Journal:  JAMA       Date:  1996-02-07       Impact factor: 56.272

6.  Growth in the use of antibiotics in the community in England and Scotland in 1980-93.

Authors:  P G Davey; R P Bax; J Newey; D Reeves; D Rutherford; R Slack; R E Warren; B Watt; J Wilson
Journal:  BMJ       Date:  1996-03-09

7.  Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study.

Authors:  V A Arason; K G Kristinsson; J A Sigurdsson; G Stefánsdóttir; S Mölstad; S Gudmundsson
Journal:  BMJ       Date:  1996-08-17

8.  Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

Authors:  D Guillemot; C Carbon; B Balkau; P Geslin; H Lecoeur; F Vauzelle-Kervroëdan; G Bouvenot; E Eschwége
Journal:  JAMA       Date:  1998-02-04       Impact factor: 56.272

9.  The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics.

Authors:  D J Austin; N J White; R M Anderson
Journal:  J Theor Biol       Date:  1998-10-07       Impact factor: 2.691

Review 10.  Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment.

Authors:  M E Pichichero
Journal:  Ann Emerg Med       Date:  1995-03       Impact factor: 5.721
View more
  9 in total

1.  Rationalised prescribing for community acquired pneumonia: a closed loop audit.

Authors:  H Clements; T Stephenson; V Gabriel; T Harrison; M Millar; A Smyth; W Tong; C J Linton
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

Review 2.  Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis.

Authors:  H Tang; T Huang; J Jing; H Shen; W Cui
Journal:  Infection       Date:  2009-10-13       Impact factor: 3.553

3.  Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study.

Authors:  P Priest; P Yudkin; C McNulty; D Mant
Journal:  BMJ       Date:  2001-11-03

4.  Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.

Authors:  Rachida el Moussaoui; Corianne A J M de Borgie; Peterhans van den Broek; Willem N Hustinx; Paul Bresser; Guido E L van den Berk; Jan-Werner Poley; Bob van den Berg; Frans H Krouwels; Marc J M Bonten; Carla Weenink; Patrick M M Bossuyt; Peter Speelman; Brent C Opmeer; Jan M Prins
Journal:  BMJ       Date:  2006-06-10

Review 5.  An Overview of Antimicrobial Stewardship Optimization: The Use of Antibiotics in Humans and Animals to Prevent Resistance.

Authors:  Md Mominur Rahman; Mst Afroza Alam Tumpa; Mehrukh Zehravi; Md Taslim Sarker; Md Yamin; Md Rezaul Islam; Md Harun-Or-Rashid; Muniruddin Ahmed; Sarker Ramproshad; Banani Mondal; Abhijit Dey; Fouad Damiri; Mohammed Berrada; Md Habibur Rahman; Simona Cavalu
Journal:  Antibiotics (Basel)       Date:  2022-05-16

Review 6.  Antimicrobial resistance determinants and future control.

Authors:  Stephan Harbarth; Matthew H Samore
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

7.  Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: a cross sectional study.

Authors:  Aref A Bin Abdulhak; Mohamad A Altannir; Mohammed A Almansor; Mohammed S Almohaya; Atallah S Onazi; Mohammed A Marei; Oweida F Aldossary; Sadek A Obeidat; Mustafa A Obeidat; Muhammad S Riaz; Imad M Tleyjeh
Journal:  BMC Public Health       Date:  2011-07-07       Impact factor: 3.295

Review 8.  Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.

Authors:  Sameer Dhingra; Nor Azlina A Rahman; Ed Peile; Motiur Rahman; Massimo Sartelli; Mohamed Azmi Hassali; Tariqul Islam; Salequl Islam; Mainul Haque
Journal:  Front Public Health       Date:  2020-11-04

9.  Dispensing of non-prescribed antibiotics in Jordan.

Authors:  Ammar Almaaytah; Tareq L Mukattash; Julia Hajaj
Journal:  Patient Prefer Adherence       Date:  2015-09-30       Impact factor: 2.711
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.